jueves, 3 de agosto de 2023

FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer

FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-trifluridine-and-tipiracil-bevacizumab-previously-treated-metastatic-colorectal-cancer

No hay comentarios:

Publicar un comentario